Literature DB >> 429413

Metabolic activity of articular cartilage in osteoarthritis. An in vitro study.

R C Thompson, T R Oegema.   

Abstract

Biochemical changes and in vitro rates of glycosaminoglycan synthesis were studied in thirty-seven samples of human articular cartilage from nineteen osteoarthritic and four normal control patients who were fifty to seventy-five years old. The samples were compared on the basis of histological grade of the arthritis, and subgroups based on the duration of disease, synovial pathological changes, joint studied, and sex were also compared. The osteoarthritic samples showed a progressive loss of glycosaminoglycans in the cartilage as the histological grade increased. In the early stages of the disease there was an increase in the chondroitin sulphate content as well as in the rate of glycosaminoglycan synthesis in several cases when the values for the osteoarthritic articular-cartilage samples were compared with those for the age-matched controls. In the late stages there was a progressive decrease in the rate of glycosaminoglycan synthesis and a relative decrease in chrondroitin sulphate synthesis compared with keratan sulphate synthesis, and these decreases were highly correlated with the histological grade.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 429413

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  26 in total

1.  Phenotypic modulation of chondrocytes as a potential therapeutic target in osteoarthritis: a hypothesis.

Authors:  T Aigner; J Dudhia
Journal:  Ann Rheum Dis       Date:  1997-05       Impact factor: 19.103

2.  Effects of tiaprofenic acid (Surgam) on cartilage proteoglycans in the rabbit joint immobilisation model.

Authors:  I Meyer-Carrive; P Ghosh
Journal:  Ann Rheum Dis       Date:  1992-04       Impact factor: 19.103

3.  Changes in cartilage proteoglycan aggrecan after intra-articular injection of interleukin-1 in rabbits: studies of synovial fluid and articular cartilage.

Authors:  C Lundberg; I Asberg; M Ionescu; A Reiner; G Smedegård; A R Poole
Journal:  Ann Rheum Dis       Date:  1996-08       Impact factor: 19.103

4.  Effects of intramuscular polysulfated glycosaminoglycan on chemical and physical defects in equine articular cartilage.

Authors:  G W Trotter; J V Yovich; C W McIlwraith; R W Norrdin
Journal:  Can J Vet Res       Date:  1989-04       Impact factor: 1.310

5.  Differential modulation of degradative and repair responses of interleukin-1-treated chondrocytes by platelet-derived growth factor.

Authors:  A K Harvey; S T Stack; S Chandrasekhar
Journal:  Biochem J       Date:  1993-05-15       Impact factor: 3.857

Review 6.  Articular cartilage and osteoarthrosis. The role of molecular markers to monitor breakdown, repair and disease.

Authors:  L S Lohmander
Journal:  J Anat       Date:  1994-06       Impact factor: 2.610

7.  Age-related accumulation of pentosidine in aggrecan and collagen from normal and degenerate human intervertebral discs.

Authors:  Sarit Sara Sivan; Eve Tsitron; Ellen Wachtel; Peter Roughley; Nico Sakkee; Frits van der Ham; Jeroen Degroot; Alice Maroudas
Journal:  Biochem J       Date:  2006-10-01       Impact factor: 3.857

8.  Regulation of xylosyltransferase I gene expression by interleukin 1β in human primary chondrocyte cells: mechanism and impact on proteoglycan synthesis.

Authors:  Mostafa Khair; Mustapha Bourhim; Lydia Barré; Dong Li; Patrick Netter; Jacques Magdalou; Sylvie Fournel-Gigleux; Mohamed Ouzzine
Journal:  J Biol Chem       Date:  2012-12-05       Impact factor: 5.157

9.  Metabolic responses of cartilage in experimentally induced osteoarthritis.

Authors:  R W Moskowitz; V M Goldberg; C J Malemud
Journal:  Ann Rheum Dis       Date:  1981-12       Impact factor: 19.103

10.  Studies of the articular cartilage proteoglycan aggrecan in health and osteoarthritis. Evidence for molecular heterogeneity and extensive molecular changes in disease.

Authors:  G Rizkalla; A Reiner; E Bogoch; A R Poole
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.